Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Endo Int'l Plc (ENDP) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 3,568,260
  • Shares Outstanding, K 222,770
  • Annual Sales, $ 3,269 M
  • Annual Income, $ -1,495 M
  • 36-Month Beta 0.62
  • Price/Sales 1.08
  • Price/Book 0.58

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.83 +14.24%
on 11/08/16
18.63 -15.19%
on 11/14/16
-2.37 (-13.04%)
since 11/02/16
3-Month
13.83 +14.24%
on 11/08/16
23.98 -34.11%
on 09/23/16
-4.02 (-20.28%)
since 09/02/16
52-Week
12.56 +25.80%
on 05/12/16
63.71 -75.20%
on 12/07/15
-45.75 (-74.33%)
since 12/02/15

Most Recent Stories

More News
BioDelivery Sciences: Can Bunvail and Belbuca's Sales Improve?

On Nov 25, 2016, we issued an updated research report on BioDelivery Sciences International, Inc. (BDSI).

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Endo International plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit - ENDP

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endo International PLC (ENDP) & Lead Plaintiff Deadline: January 6, 2017

NEW YORK, NY / ACCESSWIRE / November 24, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company")...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Endo International plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern...

Endo Reports Positive Cellulite Treatment Data on Xiaflex

Endo International plc (ENDP) announced positive data from a phase IIb study on Xiaflex

Endo Announces Positive Data from Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Highly Statistically Significant Results (P

Endo Announces Positive Data from Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Highly Statistically Significant Results (P

Endo Announces Positive Data from Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Highly Statistically Significant Results (P

INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc ("Endo" or the "Company") (Nasdaq: ENDP)....

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endo International PLC (ENDP) & Lead Plaintiff Deadline: January 6, 2017

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company") (ENDP) and certain of...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova,...

See More

Support & Resistance

2nd Resistance Point 16.34
1st Resistance Point 16.07
Last Price 15.80
1st Support Level 15.60
2nd Support Level 15.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.